Legal News Articles - Drugs/Medical
March 12, 2017. By Brenda Craig.
Washington, DC The Washington DC based watchdog group, Public Citizen, was among the first to start ringing the warning bell. In 2011 Public Citizen demanded that the FDA warn patients and doctors that the use of the popular prescription acid-reducing drugs came with serious health risks.Read [ The Watchdog Group that Rang the Bell on Anti-acid Meds ]
March 10, 2017. By Deb Hipp.
St. Louis, MO: Johnson & Johnson (J & J) won its first jury verdict out of four recent Missouri talcum powder cancer lawsuits to go to trial.Read [ Missouri Jury Finds in Favor of Johnson & Johnson on Talcum Powder Case ]
March 10, 2017. By Gordon Gibb.
San Diego, CA: A new Alere lawsuit filed earlier this month in San Diego asserts that the allegedly failed Alere INRatio measuring device was approved through the issuance of a 510(k) Clearance by the US Food and Drug Administration (FDA). The problematic measuring system, comprised of test strips and a measuring device, were subject to an FDA-sanctioned Alere recall in 2014. Lawsuits are continuing to roll in.Read [ Failed INRatio Device Fast-Tracked to Market ]
March 9, 2017. By Jane Mundy.
Washington, DC: The latest news regarding Roundup and its link to cancer doesn’t look good for Monsanto or the Environmental Protection Agency (EPA). Jess Rowland, the former Deputy Director of the EPA, may have played a major role in a cover-up to hide evidence of the possible cancer-causing glyphosate in Monsanto`s Roundup.Read [ Monsanto-Gate: Leaked Roundup Cancer Report ]
March 8, 2017. By Gordon Gibb.
Philadelphia, PA: A series of complex legal arguments and maneuvering with regard to jurisdictional issues may have served to briefly divert attention away from Invokana adverse events. However, plaintiffs are nonetheless steeled in their resolve to pursue compensation amidst allegations over Invokana linked with cardiovascular injuries and kidney failure.Read [ Invokana Lawsuits Will Remain in Federal Court In Philadelphia ]
March 7, 2017. By Gordon Gibb.
Washington, DC: Much has been written in recent years about hip implant replacement failure and the perfect storm borne from an aging population (the leading edge of Baby Boomers are entering their retirement years), and a medical device manufacturing industry rushing new designs to market bereft of adequate real-world testing through a legal FDA loophole. Coupled with the Trump Administration’s overtures that the US Food and Drug Administration is too tightly-regulated now, the die is cast for a potentially troubling future for patients assigned medical devices such as artificial hips.Read [ Hoping for a Hassle-Free Hip Implant a Roll of the Dice ]
March 7, 2017. By Deb Hipp.
New Brunswick, NJ:There are now 18,500 Risperdal lawsuits pending against Johnson & Johnson (J & J) and its subsidiary Janssen Pharmaceuticals in the US and Canada, according to Johnson & Johnson's most recent annual report.Read [ Number of Pending Risperdal Lawsuits Grows to 18,500 Cases ]
March 6, 2017. By Gordon Gibb.
Parsippany, NJ: This could evolve to a compelling year for Japanese-based pharmaceutical giant Daiichi Sankyo following the expiry of its patent exclusivity for Benicar last year and a corresponding drop in revenue for a product characterized as its global mainstay. As generics for olmesartan (Benicar) continue to gain market share in 2017, coupled with a growing number of Benicar lawsuits which number around 1,700 and climbing, industry watchers will be monitoring Daiichi in the coming months and years to see how the corporation responds, and what effect that may have on consumers.Read [ Revenues Drop While Lawsuits Rise over Benicar for Daiichi Sankyo ]
March 5, 2017. By Brenda Craig.
Seattle, WA It’s almost a century since two Canadian researchers discovered insulin could save the lives of diabetics. They believed that no one should profit from their remarkable discovery and sold the patent to the University of Toronto for $1. Changes to the production of insulin and expiring patents have changed all that. Today, insulin is big business.Read [ Fighting Back Against the High Cost of Insulin ]
March 4, 2017. By Jane Mundy.
Miami Beach, FL: A former arms dealer who made the news ten years ago and again last year when the film “War Dogs” was released is making headlines again, this time claiming that Abilify caused his compulsive behaviors.Read [ Abilify Makes Headlines ]
- Potential for Permanent Taxotere Hair Loss Not Widely Promoted By Gordon Gibb (Mar-4-17)
- Doctor from Dallas Collects $11.4 million for Blowing the Whistle on Healthcare Fraud By Brenda Craig (Mar-3-17)
- Granuflo Bellwether Case Fails to Prove Fault By Lucy Campbell (Mar-3-17)
- Defective Hip Implants: Newer Isn’t Always Better By Gordon Gibb (Mar-1-17)
- First Physiomesh Hernia Mesh Lawsuit Slated for Trial – and More Mesh Complications By Jane Mundy (Mar-1-17)
- Plaintiffs Looking for a Slam Dunk in First Xarelto Bellwether Trial This Month By Gordon Gibb (Mar-1-17)
- Canadian Transvaginal Mesh Class Action By Jane Mundy (Feb-28-17)
- Eliquis Lawsuits Moving Forward in MDL, Venue Still to be Determined By Gordon Gibb (Feb-27-17)
- Essure or Hysterectomy—the Latter May Be Preferable By Jane Mundy (Feb-27-17)
- Number of Taxotere MDL Lawsuits Surpasses 700 Cases By Deb Hipp (Feb-27-17)
- While FDA Suggests Potential for Testosterone Abuse, Health Canada Takes a Pass By Gordon Gibb (Feb-26-17)
- IVC Filter Recipient Walking Time Bomb? By Jane Mundy (Feb-25-17)
- Implanon Reviews Could Steer Women Away From the Birth Control Device By Deb Hipp (Feb-24-17)
- Talcum Powder Ovarian Cancer Whistleblower By Jane Mundy (Feb-21-17)
- Risperdal Case Load Shows No Sign of Slowing Down By Gordon Gibb (Feb-21-17)
- Government Agencies Release Recommended Warning for Labeling Drug Products Associated with Stevens-Johnson Syndrome By Deb Hipp (Feb-19-17)
- Blogger Says ‘No Thanks’ to IVC Filter By Gordon Gibb (Feb-19-17)
- Stockert 3T Heater-Cooler System Confusion and Concern By Jane Mundy (Feb-19-17)
- Qui Tam Whistleblowers and Healthcare Fraud: “It’s a Completely Criminal Enterprise” By Jane Mundy (Feb-19-17)
- Plaintiff Claims C-Qur Mesh Biologically Incompatible with Human Tissue By Gordon Gibb (Feb-19-17)
- Nurse Lives with Bard IVC Filter tine lost in her Body By Brenda Craig (Feb-16-17)
- Taxotere Hair Loss Lawsuits Moving Forward in MDL By Gordon Gibb (Feb-15-17)
- Young Mother Recounts Horrid Experience with Birth Control Implant By Gordon Gibb (Feb-15-17)
- Endoscope Disinfection Problems Extend Beyond Devices Themselves By Gordon Gibb (Feb-14-17)
- Federal Judge Dismisses Bravelle Lawsuit in Unusual Removal Situation By Deb Hipp (Feb-14-17)
- Mesothelioma Victim Washed Late Husband’s Work Clothes By Gordon Gibb (Feb-13-17)
- Former Propecia Users May Have Underlying Neurobiological Abnormalities By Deb Hipp (Feb-13-17)
- US Food and Drug Administration, FDA, St. Jude Medical Inc. By Gordon Gibb (Feb-12-17)
- Appeals: I’ve had a Few, but then Too Few to Mention? By Gordon Gibb (Feb-10-17)
- Canadian Study Finds 12 Percent of ADHD Youth Prescribed Antipsychotic Drugs Such as Risperdal By Deb Hipp (Feb-10-17)
- Surgery Patients Demand Monitoring for Potentially Deadly Infection in Class Action By Brenda Craig (Feb-9-17)
- Damning Report on FDA Approval of Power Morcellators Released By Lucy Campbell (Feb-9-17)
- New Talcum Powder Cancer Lawsuit Against Johnson & Johnson Filed By Multiple Plaintiffs By Deb Hipp (Feb-9-17)
- Federal Bair Hugger Lawsuits Climbing, Now Number 1105 in MDL By Gordon Gibb (Feb-8-17)
- Latest Defective Catheter Takes Its Place in Long Line of FDA Recalls By Deb Hipp (Feb-8-17)
- Invokana Still Invoking Concerns By Gordon Gibb (Feb-8-17)
- INRatio Class Action Headed for Trial By Brenda Craig (Feb-7-17)
- Benicar Side Effects Lawsuit Blocked from Remand to State Court By Gordon Gibb (Feb-7-17)
- Do Medication Guides for PPI Kidney Disease and Prevacid Lack Consistency? By Gordon Gibb (Feb-6-17)
- Hernia Mesh Implants: Risks Outweigh Benefits By Jane Mundy (Feb-5-17)